The treatment of Angina & Osteomalacia with vitamins

Angina and Osteomalacia: Mitamins custom make quality formulas for the treatment of Angina & Osteomalacia with vitamins. A Angina & Osteomalacia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Angina and Osteomalacia

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    200
    IU
    667%
    Calcium
    400
    mg
    40%
    Magnesium
    200
    mg
    50%
    CoQ-10
    50
    mg
    *
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    Boron
    500
    mcg
    *
    Hawthorn Extract
    250
    mg
    *
    L-Arginine
    250
    mg
    *
    L-Carnitine
    250
    mg
    *
    Taurine
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Angina and Osteomalacia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Statement On CT Colonography Study By AGA Institute
Colorectal cancer is the second-leading cause of cancer deaths, affecting both men and women nearly equally and is one of the most preventable cancers. The American Gastroenterological Association (AGA) Institute supports clinically proven technologies that increase the number of patients screened for colon cancer.The AGA Institute offers the following comments on the study by Kim et al.
Savient Announces Completion Of Patient Enrollment In Phase 3 Trials Of Puricase® For Treatment-Failure Gout
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that it has reached its Phase 3 enrollment target of 200 patients total, in the two replicate placebo-controlled six-month clinical trials. The trials assess the safety and efficacy of Puricase in patients with treatment-failure gout, under the auspices of a Special Protocol Assessment from the U.S. Food and Drug Administration.
This information concerning the support of Angina and Osteomalacia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments